News
Definitive Healthcare Q1 Review: Revenue Slumps, Structural Issues Surface, And A SELL Rating Sticks
Definitive Healthcare faces structural revenue decline, weak retention, and competitive pressure, raising long-term concerns.
Humana (NYSE:HUM) experienced a 3% price increase last week, which may have been influenced by its recent partnership with Mercy to open new primary care clinics for seniors. This expansion addresses ...
Shares of Humana Inc. HUM rose 1.39% to $234.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to 6,045.26 and the ...
Copa Holdings boasts a strong balance sheet, industry-leading margins, and resilience through crises. Click here to find out ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results